News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
390,169 Results
Type
Article (31523)
Company Profile (56)
Press Release (358590)
Section
Business (112642)
Career Advice (1318)
Deals (24008)
Drug Delivery (87)
Drug Development (59596)
Employer Resources (102)
FDA (9872)
Job Trends (9062)
News (211193)
Policy (25450)
Tag
Academia (1828)
Alliances (42052)
Alzheimer's disease (985)
Approvals (9817)
Artificial intelligence (91)
Bankruptcy (228)
Best Places to Work (7620)
Breast cancer (84)
Cancer (796)
Cardiovascular disease (63)
Career advice (1106)
CAR-T (61)
Cell therapy (177)
Clinical research (47058)
Collaboration (316)
Compensation (161)
COVID-19 (2427)
Data (805)
Diabetes (120)
Diagnostics (3421)
Drug pricing (78)
Earnings (39429)
Employer resources (94)
Events (44683)
Executive appointments (132)
FDA (10263)
Funding (231)
Gene therapy (142)
GLP-1 (569)
Government (4017)
Healthcare (11359)
Infectious disease (2509)
Inflammatory bowel disease (65)
Interviews (228)
IPO (10326)
Job creations (1745)
Job search strategy (955)
Layoffs (249)
Legal (6997)
Lung cancer (129)
Manufacturing (133)
Medical device (5883)
Medtech (5884)
Mergers & acquisitions (13763)
Metabolic disorders (357)
Neuroscience (1193)
NextGen Class of 2024 (3653)
Non-profit (2759)
Northern California (943)
Obesity (217)
Opinion (171)
Parkinson's disease (62)
Patents (75)
People (24399)
Phase I (14194)
Phase II (20439)
Phase III (16570)
Pipeline (365)
Policy (67)
Postmarket research (1839)
Preclinical (5902)
Radiopharmaceuticals (202)
Rare diseases (161)
Real estate (2572)
Regulatory (15582)
Research institute (1587)
Resumes & cover letters (196)
Southern California (769)
Startups (1878)
United States (7709)
Vaccines (580)
Weight loss (180)
Date
Today (24)
Last 7 days (430)
Last 30 days (2351)
Last 365 days (22694)
2024 (20726)
2023 (25266)
2022 (33399)
2021 (35907)
2020 (34112)
2019 (27918)
2018 (21236)
2017 (20191)
2016 (18715)
2015 (21499)
2014 (15968)
2013 (12890)
2012 (13639)
2011 (14423)
2010 (13094)
Location
Africa (567)
Arizona (69)
Asia (25502)
Australia (4589)
California (1977)
Canada (776)
China (177)
Colorado (88)
Connecticut (84)
Europe (61052)
Florida (275)
Georgia (66)
Illinois (179)
Indiana (121)
Maryland (420)
Massachusetts (1427)
Michigan (72)
Minnesota (84)
New Jersey (625)
New York (632)
North Carolina (347)
Northern California (943)
Ohio (78)
Pennsylvania (487)
South America (795)
Southern California (769)
Texas (237)
Washington State (193)
390,169 Results for "itm isotopen technologien muenchen ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ITM to Participate in Upcoming Investor Conferences
November 11, 2024
·
1 min read
Press Releases
ITM, TUM, and TUM University Hospital Sign New Framework Agreement to Advance Innovative Radiopharmaceutical Cancer Treatments
October 24, 2024
·
5 min read
Press Releases
Actineer, a Joint Venture of ITM and CNL, Begins Actinium-225 Production
October 20, 2024
·
3 min read
Business
ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of Growth
ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company announced the appointment of Dr. Andrew Cavey, as its Chief Executive Officer effective September 1, 2024.
June 20, 2024
·
3 min read
Business
ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced the appointment of Danielle Meyrick, PhD, MD, as Chief Medical Officer.
May 7, 2024
·
4 min read
Drug Development
ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Investigator-Initiated Glioblastoma Trial
The Departments of Neurosurgery and Nuclear Medicine at the University Hospital Münster, Helmholtz Munich, and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced that the first patient has been dosed in an investigator-initiated trial with ITM’s radiopharmaceutical drug candidate, ITM-31 for the potential use in glioblastoma patients.
April 23, 2024
·
4 min read
Press Releases
ITM and NTP Strengthen Global Radioisotope Production Capacities by Renewing their Technology License Agreement and Signing a Manufacturing and Supply Agreement for n.c.a. Lutetium-177
October 18, 2024
·
5 min read
ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing
ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced an equity investment of €188 million led by Temasek with participation from funds managed by BlackRock, Qatar Investment Authority, ATHOS and Carbyne.
June 6, 2024
·
7 min read
Press Releases
ITM to Present at Upcoming Radiopharmaceutical Investor Conferences in New York City
September 19, 2024
·
2 min read
Business
ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program
ITM Isotope Technologies Munich SE and Alpha-9 Oncology announced the signature of a global master clinical supply agreement to support the development of Alpha-9’s Radiopharmaceutical Therapy pipeline candidates for the treatment of cancer.
January 30, 2024
·
4 min read
1 of 39,017
Next
